May 15, 2012Pharma Newsadmin HORSHOLM, Denmark, May 15, 2012 /PRNewswire/ --Highlights:Ā Enrolment has been completed in the pivotal LCP-Tacro 3002 Phase III study in de novo kidney transplant patients. The LCP-Tacro 3002 study is ...
